Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 2,364,369	$ 888,979
Adjustments to reconcile net income to net cash provided by operating activities:
Bad debt (recovery) expense	(2,289,179)	196,806
Depreciation expense	32,104	14,820
Loss on disposal of property and equipment	18,072
Inventory reserve	(97,741)	369,757
Amortization of land use rights and yew forest assets	1,384,847	1,273,541
Sale of yew forest assets as inventory	7,754,557	4,330,465
Changes in operating assets and liabilities:
Accounts receivable	(2,483,797)	3,429,536
Accounts receivable - related parties	(5,700,808)	(4,341,860)
Other current assets	(61,132)	(158,911)
Inventories	208,439	827,706
VAT input credit	(210,763)	(409,926)
Accounts payable	52,090	(42,751)
Accounts payable - related parties		(188,284)
Accrued expenses and other payables	36,833	138,844
Advance from customer		359,687
Advance from customer- related parties		110,910
Due to related parties	28,280	(2,573)
Long-term deferred income		240,976
NET CASH PROVIDED BY OPERATING ACTIVITIES	1,036,171	7,037,722
CASH FLOWS FROM INVESTING ACTIVITIES:
Prepayments made for purchase of yew forest assets	(342,435)	(603,355)
Purchase of property and equipment	(58,372)	(39,349)
Purchase of yew forest assets	(1,313,702)	(5,427,104)
NET CASH USED IN INVESTING ACTIVITIES	(1,714,509)	(6,069,808)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from short-term borrowings	5,653,727	5,299,883
Repayments of short-term borrowings	(5,378,538)	(5,229,963)
Proceeds from related parties	66,642	1,040
NET CASH PROVIDED BY FINANCING ACTIVITIES	341,831	70,960
EFFECT OF EXCHANGE RATE ON CASH	(60,354)	(112,659)
NET (DECREASE) INCREASE IN CASH	(396,861)	926,215
CASH - Beginning of the year	563,792	742,294
CASH - End of the year	166,931	1,668,509
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	254,559	235,594
Income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES
Operating expense paid by related party		853
Payable for acquisition of yew forests- related party		$ 171,814

Yew Bio-Pharm Group, Inc. 10-Q